Calibre Launches “Causal Health Navigation” and Raises $3.3M to Advance Causal AI-Driven Healthcare
Calibre, a London-based healthtech company, has emerged from stealth to introduce a new category called Causal Health Navigation, combining clinical expertise with causal AI to help individuals understand the true drivers behind their health outcomes and how to improve them.
The company has raised $3.3 million in pre-seed funding, led by Berlin-based Amino Collective, with participation from Daybreak Ventures, Cocoa Ventures, and a network of experienced founders, operators, and medical experts. Notable angel investors include Gousto founder Timo Boldt and N26 co-founder Maximilian Tayenthal.
Founded in 2025 by Alexander Weber (CEO), Ben Levy (CTO), and Dr. Reinhold Innerhofer (CMO), the team brings extensive experience in scaling healthtech companies beyond €100 million in revenue.
The platform integrates clinicians, diagnostics, and AI to deliver personalised health plans starting at £69 per month. At its core is causal AI, which goes beyond identifying correlations in health data to determining cause-and-effect relationships, enabling users to understand not just what is happening, but why—and what actions can address root causes.
Previously, this level of personalised insight required costly teams of private specialists, often costing thousands annually. Calibre aims to democratise access through a subscription model.
Alex Weber commented:
"Left alone by the system, people are now in the era of health guesswork. Calibre is what comes next: a proactive health partner for life that deeply understands your full picture, tells you what's actually driving your health, and guides you as your health evolves."
The funding will be used to advance product development, strengthen clinical infrastructure, and scale its subscriber base in the UK, ahead of its next funding round.
Calibre enters a competitive yet evolving market. Companies such as ZOE and Numan have already demonstrated strong consumer demand for subscription-based personalised healthcare solutions in the UK.
Calibre’s key differentiation lies in its causal reasoning layer, designed to explain—not just describe—the relationships between lifestyle, biomarkers, and health outcomes.
